Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $5.0250 (-0.69%) ($5.0250 - $5.0250) on Fri. May. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.89% (three month average) | RSI | 59 | Latest Price | $5.0250(-0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADAP declines -0.4% a day on average for past five trading days. | Weekly Trend | ADAP advances 2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) PEJ(-231%) SKYY(-723%) XLRE(-51%) XLU(-33%) XLC(-70%) | Factors Impacting ADAP price | ADAP will decline at least -1.945% in a week (0% probabilities). BLOK(-61%) IBB(-40%) BOTZ(-9%) EWJ(67%) XLC(-70%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.945% (StdDev 3.89%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.96(1.31%) | 10 Day Moving Average | $5(0.5%) | 20 Day Moving Average | $4.98(0.9%) | To recent high | -13.2% | To recent low | 0% | Market Cap | $777m | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |